Iveric Bio Stock Price, News & Analysis
Company Description
Iveric Bio (NASDAQ: ISEE) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $5.5B.
ISEE stock has declined 100.0% over the past year.
This page provides a comprehensive overview of ISEE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Iveric Bio (ISEE) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $5.5B, ISEE is classified as a mid-cap stock with approximately 138.0M shares outstanding.
Latest News
Iveric Bio has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings. View all ISEE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ISEE Company Profile & Sector Positioning
Iveric Bio (ISEE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.